Clinical trial

A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma

NCT00461812 · Johns Hopkins University, Other · Terminated

Key facts

NCT number NCT00461812
Title A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
Official title A Single-Blind, Randomized, Positive-controlled Study to Compare Monotherapy With an Inhaled Corticosteroid (Mometasone) to Combination Therapy With an Inhaled Corticosteroid + a Long-Acting Bronchodilator (Advair) in Patients With Milder Persistent Asthma
Lead sponsor Johns Hopkins University, Other
Collaborators Schering-Plough Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Asthma
Intervention type Drug
Interventions Mometasone, Advair
Enrollment 33
Start date Apr 1, 2007
Primary completion Jan 19, 2010
Completion Jan 19, 2010
First posted Apr 18, 2007
Last update posted Sep 20, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies